221 related articles for article (PubMed ID: 11923467)
1. Selective intranuclear redistribution of PPAR isoforms by RXR alpha.
Akiyama TE; Baumann CT; Sakai S; Hager GL; Gonzalez FJ
Mol Endocrinol; 2002 Apr; 16(4):707-21. PubMed ID: 11923467
[TBL] [Abstract][Full Text] [Related]
2. A regulatory role for RIP140 in nuclear receptor activation.
Treuter E; Albrektsen T; Johansson L; Leers J; Gustafsson JA
Mol Endocrinol; 1998 Jun; 12(6):864-81. PubMed ID: 9626662
[TBL] [Abstract][Full Text] [Related]
3. Retinoid X receptor dominates the nuclear import and export of the unliganded vitamin D receptor.
Prüfer K; Barsony J
Mol Endocrinol; 2002 Aug; 16(8):1738-51. PubMed ID: 12145331
[TBL] [Abstract][Full Text] [Related]
4. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators.
Westin S; Kurokawa R; Nolte RT; Wisely GB; McInerney EM; Rose DW; Milburn MV; Rosenfeld MG; Glass CK
Nature; 1998 Sep; 395(6698):199-202. PubMed ID: 9744281
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors.
DiRenzo J; Söderstrom M; Kurokawa R; Ogliastro MH; Ricote M; Ingrey S; Hörlein A; Rosenfeld MG; Glass CK
Mol Cell Biol; 1997 Apr; 17(4):2166-76. PubMed ID: 9121466
[TBL] [Abstract][Full Text] [Related]
6. Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor delta-mediated transactivation.
Krogsdam AM; Nielsen CA; Neve S; Holst D; Helledie T; Thomsen B; Bendixen C; Mandrup S; Kristiansen K
Biochem J; 2002 Apr; 363(Pt 1):157-65. PubMed ID: 11903058
[TBL] [Abstract][Full Text] [Related]
7. The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators.
Tagami T; Lutz WH; Kumar R; Jameson JL
Biochem Biophys Res Commun; 1998 Dec; 253(2):358-63. PubMed ID: 9878542
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor.
Jeyakumar M; Tanen MR; Bagchi MK
Mol Endocrinol; 1997 Jun; 11(6):755-67. PubMed ID: 9171239
[TBL] [Abstract][Full Text] [Related]
9. A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands.
Crowe DL; Chandraratna RA
Breast Cancer Res; 2004; 6(5):R546-55. PubMed ID: 15318936
[TBL] [Abstract][Full Text] [Related]
10. Nuclear compartmentalization of N-CoR and its interactions with steroid receptors.
Wu Y; Kawate H; Ohnaka K; Nawata H; Takayanagi R
Mol Cell Biol; 2006 Sep; 26(17):6633-55. PubMed ID: 16914745
[TBL] [Abstract][Full Text] [Related]
11. Discrete roles for peroxisome proliferator-activated receptor gamma and retinoid X receptor in recruiting nuclear receptor coactivators.
Yang W; Rachez C; Freedman LP
Mol Cell Biol; 2000 Nov; 20(21):8008-17. PubMed ID: 11027271
[TBL] [Abstract][Full Text] [Related]
12. PPAR gamma/RXR as a molecular target for diabetes.
Lenhard JM
Recept Channels; 2001; 7(4):249-58. PubMed ID: 11697231
[TBL] [Abstract][Full Text] [Related]
13. Subtype specific effects of peroxisome proliferator-activated receptor ligands on corepressor affinity.
Stanley TB; Leesnitzer LM; Montana VG; Galardi CM; Lambert MH; Holt JA; Xu HE; Moore LB; Blanchard SG; Stimmel JB
Biochemistry; 2003 Aug; 42(31):9278-87. PubMed ID: 12899614
[TBL] [Abstract][Full Text] [Related]
14. Ligands for the peroxisome proliferator-activated receptor-gamma and the retinoid X receptor-alpha exert synergistic antiproliferative effects on human coronary artery smooth muscle cells.
Benson S; Padmanabhan S; Kurtz TW; Pershadsingh HA
Mol Cell Biol Res Commun; 2000 Mar; 3(3):159-64. PubMed ID: 10860864
[TBL] [Abstract][Full Text] [Related]
15. Dimerization with retinoid X receptors promotes nuclear localization and subnuclear targeting of vitamin D receptors.
Prüfer K; Racz A; Lin GC; Barsony J
J Biol Chem; 2000 Dec; 275(52):41114-23. PubMed ID: 11001945
[TBL] [Abstract][Full Text] [Related]
16. Reduced intranuclear mobility of APL fusion proteins accompanies their mislocalization and results in sequestration and decreased mobility of retinoid X receptor alpha.
Dong S; Stenoien DL; Qiu J; Mancini MA; Tweardy DJ
Mol Cell Biol; 2004 May; 24(10):4465-75. PubMed ID: 15121864
[TBL] [Abstract][Full Text] [Related]
17. Stabilization of peroxisome proliferator-activated receptor alpha by the ligand.
Hirotani M; Tsukamoto T; Bourdeaux J; Sadano H; Osumi T
Biochem Biophys Res Commun; 2001 Oct; 288(1):106-10. PubMed ID: 11594759
[TBL] [Abstract][Full Text] [Related]
18. Expression of PPAR and RXR isoforms in the developing rat and human term placentas.
Wang Q; Fujii H; Knipp GT
Placenta; 2002; 23(8-9):661-71. PubMed ID: 12361685
[TBL] [Abstract][Full Text] [Related]
19. Subnuclear trafficking of estrogen receptor-alpha and steroid receptor coactivator-1.
Stenoien DL; Mancini MG; Patel K; Allegretto EA; Smith CL; Mancini MA
Mol Endocrinol; 2000 Apr; 14(4):518-34. PubMed ID: 10770489
[TBL] [Abstract][Full Text] [Related]
20. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor.
Tontonoz P; Singer S; Forman BM; Sarraf P; Fletcher JA; Fletcher CD; Brun RP; Mueller E; Altiok S; Oppenheim H; Evans RM; Spiegelman BM
Proc Natl Acad Sci U S A; 1997 Jan; 94(1):237-41. PubMed ID: 8990192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
